paclitaxel cationic liposome (CSPCHA131)
/ CSPC Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
January 06, 2021
A Study of CSPCHA131 in Patients With Advanced Solid Tumor
(clinicaltrials.gov)
- P1; N=100; Recruiting; Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.; Not yet recruiting ➔ Recruiting
Clinical • Enrollment open • Oncology • Solid Tumor
March 30, 2020
A Study of CSPCHA131 in Patients With Advanced Solid Tumor
(clinicaltrials.gov)
- P1; N=100; Not yet recruiting; Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Clinical • New P1 trial
1 to 2
Of
2
Go to page
1